News in Research
2008
August 18, 2008
Researchers suggest that latitude and sex ratio trends in the
incidence of multiple sclerosis may be shifting
August 13, 2008
Biogen Idec and Elan Pharmaceuticals
informed drug regulatory authorities about two new confirmed
cases of
PML(progressive
multifocal leukoencephalopathy) in individuals who were taking
Tysabri® (natalizumab) as a monotherapy (not in combination
with other therapies).
August 13, 2008
Smoking is a risk factor for early conversion to clinically definite
multiple sclerosis
August 13, 2008
Sleep problems in people with MS are prevalent
July 7, 2008
Effectiveness of Rehabilitation Intervention in
Persons with Multiple Sclerosis: A randomized controlled trial
July 3, 2008
Laquinimod Results Published: Oral Drug Reduces
Disease Activity in Phase 2 Study
June 27, 2008
Molecule Strikes Balance in Immune System and
May Be Key to Autoimmune Attack in MS
June 13, 2008
Serious Infections Experienced by Two People Participating in
Clinical Trials of FTY720 for MS
June 11, 2008
Fampridine-SR Improves Walking Speed in All Types
of MS in Second Phase 3 Study
June 10, 2008
New Study Suggests Immune Genes Help Determine Sites of MS Damage and Symptoms
May 23, 2008
Progress on Experimental Therapies for MS, and
Much More, Reported at the American Academy of Neurology Meeting
May 15, 2008
Stem Cell Treatments in China
April 29, 2008
Disappointing Results from Trial of Rituximab
in Primary Progressive MS
April 22, 2008
Investigators Explore MS Risk Conferred by Combination of Gene
and Virus
April 21, 2008
Norwegian Researchers Confirm Higher Rates of Symptoms of Depression
and Anxiety in People with MS
April 3, 2008
Combined treatment with atorvastatin and minocycline suppresses
severity of EAE
April 2, 2008
Acne medication may delay progress of multiple
sclerosis
March 27, 2008
Compound Protects Nerves from Injury in National MS Society-funded
Study of Mice with Progressive MS
February 28, 2008
"Street" Marijuana Harmful
to Cognitive Function in MS Patients
February 19, 2008
Phase ll trial suggests Rituximab may reduce MS Disease Activity
January 16, 2008
MS Therapy may help delay conversion from CIS to clinically
definite MS
January 11, 2008
Two year pilot study suggests that
combination therapy with interferon Beta-1b and azathioprine
may help slow the course of SPMS
January 9, 2008
Large-scale analysis from Nova
Scotia suggests that disease-modifying drugs for MS are effective
in reducing
disability
progression
in people whose MS started with relapses
2007
November 6, 2007
Researchers Report Findings on Antibody That Stimulates Myelin
Repair
October 31, 2007
Research Progress Reported at International
ECTRIMS Meeting
October 31, 2007
Eye Scan May Help Diagnose, Treat MS
October 25, 2007
Acne medication may delay
progress of multiple sclerosis
September 19, 2007
Parental smoking at home and the risk of childhood-onset multiple sclerosis in children
August 17, 2007
Experimental MS vaccine shows beneficial changes
in immune system
August 14, 2007
Interferon injection may delay disability accumulation
August 8, 2007
Study Finds Early Sun Exposure Associated with Reduced Risk of
MS
July 31, 2007
International Collaborators Identify New Genetic
Risk Factors for MS
July 25, 2007
A timing-of-birth effect on risk for multiple sclerosis
July 23, 2007
Immune system variations may underlie differences
in MS between African Americans and Caucasians
July 18, 2007
ACTRIMS and CMSC
meetings focus on emerging MS therapies and quality of life issues
June 2007
MS Disease-Modifying
Therapies in Canada only
May 24, 2007
Easier access to multiple
sclerosis treatments will reduce overall healthcare costs: MS
Society
May 8, 2007
The Canadian
endMS Research Conference - Banff, Alberta
- December 10 to 13, 2007
May 2007
Progress on Experimental
Therapies for MS, and Much More, Reported at the American Academy
of Neurology Meeting - April 28 to
May 4, 2007
April 13, 2007
Researchers Stop MS-like disease in Mice by Targeting a Blood
Protein
April 13, 2007
Frequently Asked Questions on Tysabri
February 22, 2007
Clinical trial of oral therapy in relapsing remitting MS
February 22, 2007
Pregnancy hormone key to repairing nerve cell damage
February 12, 2007
Benign MS
January 29, 2007
Clinical trial results
for oral therapy fingolimod show reduction of disease activity:
Larger study now recruiting participants
January 24, 2007
Clinical trial of MBP8298 expands to United States
January 4, 2007
Later onset of MS does
not necessarily lead to worse outcome: University of British
Columbia study
Back to top
2006
November 22, 2006
Sex Hormone Trial in Women with MS Launched
November
1, 2006
Abnormal liver test results found in people with multiple sclerosis
in placebo arms of clinical trials
October 31, 2006
Canadian
study finds MS increasing among women
October 4, 2006
Health Canada approves Tysabri for treatment of relapsing MS
September 29, 2006
Vitamin
B3 protects nerve tissue from further damage in mice with MS-like
disease
September 6, 2006
Transmission of MS to children: Study finds men transmit MS more often to their children than do women
August
22, 2006
Clinical trial of oral therapy: Fingolimod study will involve 1,250
participants
August 10, 2006
Health
Canada approves Betaseron for treatment of first clinical
event suggestive
of MS
August
9, 2006
Study
suggests tetanus vaccination associated with lower risk of
developing MS
August
8, 2006
Place
of residence in childhood may influence development of MS
risk
July 27, 2006
Small study combines Novantrone and Copaxone as potential MS treatment
June 23, 2006
Small Edmonton-based
clinical trial shows some slowing of disease progression
June 2, 2006
FDA approves Tysabri's
return to market in USA for relapsing MS
May 2, 2006
MS experts estimate number
of Canadians with MS is 55,000 to 75,000
April 20, 2006
Reporting from the AAN:
Promising MS Clinical Trial Results
April 7, 2006
Recruitment of participants underway for combination
therapy study
April 7, 2006
Clinical trial for
oral Lipitor still enrolling participants for study
February-24-2006
Clinical trial underway
for new monoclonal antibody daclizumab
February-24-2006
Tysabri Update: FDA permits some clinical
trial participants to resume treatment
Jan-24-2006
BC researchers find disability progression in MS is slower
than previously reported
Jan-20-2006
Status of rituximab in multiple sclerosis
back
to top
|
